Search results

The Minister of Labour — (a) by virtue of the power conferred on him by section 76 and 180(6) and (7) of the Factories Act 1961 and of all other powers enabling him in that behalf; and

The purpose of this paper is to describe and summarize the recent emergence of NPS onto the drug market. To show the international and national responses, legal and guidance. To indicate some of the challenges NPS present to jurisdictions. To indicate some of the challenges NPS present to treatment agencies. To outline what is known about prevalence and effects.

A narrative account of the substances becoming known and the response made by jurisdictions.

The use and effects of NPS are slowly becoming known and exchanged between jurisdictions and treatment agencies. The user group appears to differ from the “traditional” substance users groups with which agencies are familiar. The use of the internet is a characteristic of this new market and user group.

New substances are constantly being identified. Previous treatment approaches may not be fully relevant to NPS. The new area of cognition enhancement is being gradually realized.

Treatment agencies need to develop new approaches, both to treat the effects of NPS use and to attract NPS users, who do not identify as “drug users”.

A new user group appears to be emerging. Cognition enhancement is a feature of NPS composition and use/attraction.

An attempt to summarize existing understanding of NPS use and marketing and to predict future trends and needs.

This chapter explores the norms and assumptions that frame and sustain international drug policy and the international drug control regime. Drug policy is conceptualised as a ‘policy fiasco’ that persists despite extensive evidence of goal failure. The absence of effective monitoring and evaluation, impact assessment, stakeholder participation and mainstreaming of rights-based approaches, conflict sensitivity and gender sensitivity is emphasised, substantiating the argument that drug policy is a case study of ‘institutional path dependence’. Drug policy has repeatedly missed targets for achievement of a ‘drug free world’. This is explained through reference to the counterproductive and ‘unintended consequences’ of a drug policy approach of criminalisation. The impacts of drug policy enforcement are shown to be negative, pernicious and disproportionately born by the poor, by vulnerable communities and those subject to discrimination on account of race, gender and class.

The flux residues on almost all soldered printed circuit boards are removed using the chlorofluorocarbon (CFC) 113. In just one year's time production of this solvent will almost certainly be curtailed, on a scale agreed internationally. This is a major issue that needs to be addressed urgently by the electronics assembly industry worldwide. This paper presents (i) the background that has led to the restrictions being placed on production and consumption of solvent 113, (ii) the international agreement and timetable for the implementation of the restrictions and (iii) the perceived opportunities that are available to the electronics assembly industry to meet this challenge.

The purpose of this paper is to illustrate the history of relevant legislation before and after the 1971 Misuse of Drugs Act (MDA).

A chronological narrative of laws and reports with concluding discussion.

That UK legislators have not made use of the evidence base available to them and have favoured enforcement rather than treatment approaches. That current UK practice has exacerbated not contain the use of and harms caused by illegal drugs.

The paper does not cover all relevant documents, especially those from non-governmental sources.

The practical implications centre on the failure of consecutive governments to reflect on and review the impact of current legislation, especially on people who use drugs.

That the situations of people who use drugs are currently ignored by the government and those proven responses which save lives and reduce harm are rejected.

The paper attempts to show the historical contexts of control and dangerousness of which the MDA is one instrument.

This paper aims to analyse the fundamental principles of the main international conventions against use of drug and to verify if it would be preferable to let European Member States adopt specific measures according to own needs at a national level.

The research uses a comparative approach by examining the different national legislations in respect of the discipline of the international conventions for finding analogies and differences between them.

The research has discovered a wide variation in the criteria for triggering a legislative response and in the penalties for non-compliance. Nevertheless, there seems to be a trend towards countries focusing on penalising supply rather than possession of these substances.

To maintain a common international level in fighting against the use and commerce of drug to enforce the effectiveness of national regulations.

The achievement of a high level of health protection, well-being and social cohesion to prevent and reduce drug use, dependence and drug-related damage to health and society.

To ensure a high level of security for the general public by taking action against drug production, cross-border trafficking in drugs and the diversion of chemical precursors used in drug production, as well as by intensifying preventive action against drug-related crime through effective cooperation, embedded in a joint approach.

This is a fast-moving area of law, which continues to evolve for the different new substances being introduced in international drug traffic, so different solutions to the problem can be found by national legislators who need to be coordinated at an international level.

Presents information on the Drug abuse resistance education (DARE) program, a set of 17 lessons on drug resistance given by police officers to sixth grade children. Measures attitudes toward drug use and degree of reported use. Indicates that DARE is successful in providing information but that the levels of reported behavior do not show significant improvement in self‐reported drug use compared to two control groups. Urges caution in expanding the program, since positive results are limited at present.

Talk around Britain's application to enter the European Economic Community goes on; it has never really ceased since the first occasion of the French veto, although in the last year or so, the airy promise of the first venture has given way to more sober thoughts on the obstacles to joining and the severe burdens to be carried not only by the British people but by many of our kith and kin beyond the seas if the country becomes a full member of the Community.

The landscape for international drug policy is shifting rapidly as the tensions between the objectives, assumptions and activities that are being introduced at local level are tearing apart the assumptions on which the system was founded. Countries are divided into camps that pursue different aims with drug policy. In addition to an established distinction between those that seek to reduce drug harms and those pursuing a vision of a drug-free world, some UN member states have established licit markets for products that the conventions hold are available for medical and scientific purposes. This incongruence is matched by states in the other camp who apply capital and corporal punishment ostensibly in pursuit of a public health objective. These differences over underlying values, but also in the use of evidence, and interpreting the purpose of the drug control system are no longer reconcilable. While there is pressure on maintaining the system, it no longer serves an organic function and continues mainly for the benefit of constituent members. With the dissolution of US leadership, drug policy is no longer operating within an effective international framework.

Few regret the passing of an old year, with its darkening days and cold nights, its message fading as the voice weakens. A new year always looks more attractive with hopes of better things to come, but an occasional look back over one's shoulder, as it were, is seldom completely without profit, for experience can sometimes be more potent than hope. 1968 seemed to have more than its share of uncertainties, tragedies and disasters, in this country and in the world at large. An unsure economic state, to say nothing of monetary confusion, was reflected in every field of industry and public administration, but in the field of food quality and purity control, steady progress towards a comprehensive system of food standards, of hygiene and of food additive control was maintained. In fact, the year may be seen as not an entirely unfruitful one, with one or two events which may well prove to be landmarks.